In numerous cancer types, including ACC, CESC, GBM, KIRC, LIHC, LUSC, PAAD, and UVM, heightened PABPN1 expression corresponded to a poorer prognosis. Here, PABPN1 is linked to pancreatic adenocarcinoma.